ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 662191 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 662191; 2) Community: the network communities that were significantly associated with the response to NSC 662191; 3) Molecule: the relationships between components within communities and NSC 662191; 4) MDR: the compounds that were significantly associated with the NSC 662191.

NSC Compound Enrichment Correlation
NSC 64111 Null 0.0454469012959173 0.15105293
NSC 645306 Null 0.0454469012959173 0.26038268
NSC 658368 Null 0.0454469012959173 0.18698773
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0454469012959173 0.09289926
NSC 100071 component of Halotex 0.0459335986102865 0.28049881
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0459335986102865 0.39658083
NSC 142475 Null 0.0459335986102865 0.26661713
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0459335986102865 0.25919224
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0459335986102865 0.085747392
NSC 180973 Tamoxifen citrate 0.0459335986102865 0.23000457
Total:121  Current:110    [First] [Prev] [Next] [Last]